Filing Details
- Accession Number:
- 0001415889-24-015542
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-05 16:04:58
- Reporting Period:
- 2024-06-03
- Accepted Time:
- 2024-06-05 16:04:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 744218 | Celldex Therapeutics Inc. | CLDX | In Vitro & In Vivo Diagnostic Substances (2835) | 133191702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1838114 | A. Freddy Jimenez | C/O Celldex Therapeutics, Inc. 53 Frontage Road, Suite 220 Hampton NJ 08827 | Svp & General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-03 | 8,006 | $10.38 | 33,930 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-03 | 8,006 | $33.60 | 25,924 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (Right to Buy) | Disposition | 2024-06-03 | 8,006 | $0.00 | 8,006 | $10.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,994 | 2030-06-18 | No | 4 | M | Direct |
Footnotes
- 25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Billionaire Hedge Funds
